AzTrials
AzTrials

Dental PhobiaPhase 2VR-DENTNCT03098134

The Efficacy of a VR Enhanced Video Exposure Therapy for Dental Phobia

A Phase 2 study testing Behavior Therapy and Health Education in people with Dental Phobia, run by Ruhr University of Bochum.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluation of a one session VR - enhanced Video exposure therapy for dental phobia. Diagnosed dental phobics will be randomly assigned to one of two conditions: (1) Psychoeducation + VR exposure (2) Psychoeducation + Video Control treatment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dental Phobia
What is being tested?
Behavior Therapy and Health Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
Apr 2017to 1 May 2018
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosed Specific Dental Phobia

Who cannot join

  • Schizophrenia or other Psychotic Illnesses
  • Bipolar Disorder
  • Chronic Headache
  • other neurological disorders such as epilepsy
  • Hearing problems

Trial locations and contacts

No sites are listed yet.

Dirk Adolph, Dr. contact

+492343223177

dirk.adolph@rub.de

Andre Wannemueller, Dr. contact

+492343223106

andre.wannemueller@rub.de

About this study

Official title: The Efficacy of a VR Enhanced Video Exposure Therapy for Dental Phobia - a Randomized Controlled Trial

Evaluation of a one session VR - enhanced Video exposure therapy for dental phobia. Diagnosed dental phobics will be randomly assigned to one of two conditions: (1) Psychoeducation + VR exposure (2) Psychoeducation + Video Control treatment. Prior to getting the therapy, participants will be evaluated with a questionnaire battery, diagnosed with a structured clinical interview and will participate in a psychophysiological symptom assessment. Then, after a 2-week waiting period, participants again fill in questionnaires, and the Intervention will take place. Within 2-weeks after the second questionnaire assessment participants will be screened with the structured interview again and will fill in questionnaires.

Conditions
Dental Phobia
Being tested
Behavior Therapy, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavior TherapyBehavioural

    Virtual Reality and Video based Exposure Therapy

  • Health EducationOther

    Video based health education covering common myths and false believes about dental surgeries

Study groups in NCT03098134
Study groupRoleWhat they receive
VR-Video-ExposureExperimentalNot described
Receives: Behavioral: Behavior Therapy
Education-Video-Active comparatorNot described
Receives: Other: Health Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Subjective Dental Anxiety

    Assessed at time 0 (at inclusion) 1 (pre therapy, two weeks after inclusion), 2(post therapy, 2 weeks after time 1) and at follow up (4 month after time 0) with Dental Anxiety Scale (DAS, 4-item scale, range 4-20)

    Measured: 4 month

  2. Change in Dysfunctional Dental Cognitions

    Assessed with Dental Cognition Questionnaire (DCQ, 38 dichotomous items, range 0-38) Assessed at time 0 (at inclusion), time 1 (pre therapy, two weeks after time 0), time 2 (post therapy, 2 weeks after time 1) and at follow up (4 month after time 0)

    Measured: 4 months

Secondary outcomes (1)
  1. Change in Psychophysiological defensive reactivity

    Participants will take part in a passive Picture viewing paradigm. They will be exposed to dental anxiety related Pictures, generally negative pictures, neutral, and positive pictures. Outcome measures will be withdrawal-related motor responding (assessed with the startle-reflex), as well as heart frequency change towards the pictures, The task will be applied at inclusion (time 0) and post therapy (4 weeks after inclusion)

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2017
  2. Study startApr 2017 (estimated)
  3. Primary completion31 Dec 2017 (estimated)
  4. Study completion1 May 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03098134
Sponsor's protocol ID
VR-DENT-1
Acronym
VR-DENT
Status last verified
Mar 2017
First submitted
14 Mar 2017
Last updated
31 Mar 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Behavior Therapy and Health Education in people with Dental Phobia, run by Ruhr University of Bochum.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dirk Adolph, Dr. (+492343223177, dirk.adolph@rub.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Subjective Dental Anxiety (time frame: 4 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in